Effects of erythropoietin and androgens on erythroid stem cells after their selective suppression by BCNU.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002330:Carmustine / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D004905:Erythrocyte Aging; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D000860:Hypoxia; D007501:Iron / Q000378:metabolism; D007504:Iron Radioisotopes; D051379:Mice; D009277:Nandrolone / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects; D011086:Polycythemia / Q000097:blood / Q000209:etiology; D011409:Propylene Glycols / Q000494:pharmacology; D011828:Radiation Chimera; D013154:Spleen / Q000166:cytology; D013739:Testosterone / Q000494:pharmacology*
D007504:Iron Radioisotopes; D011409:Propylene Glycols; D004921:Erythropoietin; D013739:Testosterone; D009277:Nandrolone; D007501:Iron; D002330:Carmustine